Clinical Trial Update: Performance Status During Treatment With Pemetrexed in Patients With NSCLC

View source ↗

Summary

This update summarizes performance status outcomes observed during pemetrexed treatment in patients with non-small cell lung cancer. The study status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non Small Cell Lung Cancer | Status: COMPLETED